Analysis of clinical effects and safety of entecavir treatment to chronic hepatitis B patients; multicenter pilot study
Not Applicable
- Conditions
- Chronic hepatitis B
- Registration Number
- JPRN-UMIN000030845
- Lead Sponsor
- Hiroshima university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who have hypersensitivity to entecavir 2. Patients who have a renal dysfunction (eGFR<50mL/min/1.73m2) or who need hemodialysis due to chronic renal failure 3. Patients who have malignacies 4. Patients who were infected with both hepatitis B virus and the other viruses, such as human immunodeficiency virus or hepatitis C virus 5. Pregnant or lactating women or women who may be pregnant 6. Female patients who want pregnancy, Male patients who may be pregnant by pregnant women 7. Patients who was judged unreasonable to carry out this study by the research doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method